1.Burden of alcohol use disorder, alcohol-related liver disease, and alcohol-related liver cancer: Editorial on “Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000–2021
Youxin WANG ; Noriko OZA ; Jazleen LEO ; Ashok CHOUDHURY ; Daniel Q. HUANG
Clinical and Molecular Hepatology 2025;31(2):654-657
2.Vibration-controlled transient elastography in shaping the epidemiology and management of steatotic liver disease: Editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017–2023”
Xiao-Dong ZHOU ; Terry Cheuk-Fung YIP ; Daniel Q HUANG ; Mark Dhinesh MUTHIAH ; Mazen NOUREDDIN ; Ming-Hua ZHENG
Clinical and Molecular Hepatology 2025;31(2):620-624
3.Burden of alcohol use disorder, alcohol-related liver disease, and alcohol-related liver cancer: Editorial on “Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000–2021
Youxin WANG ; Noriko OZA ; Jazleen LEO ; Ashok CHOUDHURY ; Daniel Q. HUANG
Clinical and Molecular Hepatology 2025;31(2):654-657
4.Vibration-controlled transient elastography in shaping the epidemiology and management of steatotic liver disease: Editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017–2023”
Xiao-Dong ZHOU ; Terry Cheuk-Fung YIP ; Daniel Q HUANG ; Mark Dhinesh MUTHIAH ; Mazen NOUREDDIN ; Ming-Hua ZHENG
Clinical and Molecular Hepatology 2025;31(2):620-624
5.Burden of alcohol use disorder, alcohol-related liver disease, and alcohol-related liver cancer: Editorial on “Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000–2021
Youxin WANG ; Noriko OZA ; Jazleen LEO ; Ashok CHOUDHURY ; Daniel Q. HUANG
Clinical and Molecular Hepatology 2025;31(2):654-657
6.Vibration-controlled transient elastography in shaping the epidemiology and management of steatotic liver disease: Editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017–2023”
Xiao-Dong ZHOU ; Terry Cheuk-Fung YIP ; Daniel Q HUANG ; Mark Dhinesh MUTHIAH ; Mazen NOUREDDIN ; Ming-Hua ZHENG
Clinical and Molecular Hepatology 2025;31(2):620-624
9.Hair transplantation in wound healing and scar repair in special areas.
Zhewei HUANG ; Xifei QIAN ; Yanwen XU ; Samuel Tumaini KAINDI ; Collins Daniel PAKAYA ; Jufang ZHANG
Chinese Journal of Reparative and Reconstructive Surgery 2025;39(5):647-654
OBJECTIVE:
To review recent advances in the application of hair transplantation in wound healing and scar repair in special areas.
METHODS:
An extensive review of the literature on the application of hair transplantation in wound healing and scar repair in special areas was conducted, focusing on cellular functions, molecular mechanisms, and clinical applications.
RESULTS:
Hair transplantation has been shown to effectively promote wound healing and scar repair in special areas. The underlying mechanisms are complex, but current understanding emphasizes a strong association with hair follicle-associated stem cells (including epidermal stem cells, dermal papilla cells, dermal sheath cells, etc).
CONCLUSION
The application of hair transplantation in wound healing and scar repair in special areas remains in its early stages. Further investigation into its mechanisms of action is essential, and randomized controlled trials are needed to establish its efficacy.
Humans
;
Wound Healing/physiology*
;
Cicatrix/therapy*
;
Hair/transplantation*
;
Hair Follicle/transplantation*
10.Global incidence and prevalence of nonalcoholic fatty liver disease
Margaret LP TENG ; Cheng Han NG ; Daniel Q. HUANG ; Kai En CHAN ; Darren JH TAN ; Wen Hui LIM ; Ju Dong YANG ; Eunice TAN ; Mark D. MUTHIAH
Clinical and Molecular Hepatology 2023;29(Suppl):S32-S42
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease worldwide. The estimated global incidence of NAFLD is 47 cases per 1,000 population and is higher among males than females. The estimated global prevalence of NAFLD among adults is 32% and is higher among males (40%) compared to females (26%). The global prevalence of NAFLD has increased over time, from 26% in studies from 2005 or earlier to 38% in studies from 2016 or beyond. The prevalence of NAFLD varies substantially by world region, contributed by differing rates of obesity, and genetic and socioeconomic factors. The prevalence of NAFLD exceeds 40% in the Americas and South-East Asia. The prevalence of NAFLD is projected to increase significantly in multiple world regions by 2030 if current trends are left unchecked. In this review, we discuss trends in the global incidence and prevalence of NAFLD and discuss future projections.

Result Analysis
Print
Save
E-mail